Victoza is widely known as a diabetes medication, but many patients also experience weight loss while using it. Here’s how liraglutide changes appetite, digestion, and metabolic health — plus the risks physicians monitor closely.
Some patients stop Ozempic and other weekly GLP-1 drugs despite improved blood sugar results. Persistent nausea, appetite suppression, treatment fatigue, and lifestyle burden may all contribute to long-term discontinuation.
Exenatide helped define the modern GLP-1 era long before Ozempic became mainstream. This evidence-based review explains how exenatide worked, why Bydureon and Byetta were discontinued, and why stopping GLP-1 therapy often leads to rebound weight gain without a structured maintenance plan.
Saxenda and Wegovy both belong to the GLP-1 drug class, but their differences in dosing, effectiveness, and appetite control may significantly influence long-term weight-loss habits. Here’s how semaglutide and liraglutide compare in real-world obesity management.